Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2022 Aug 10;14(16):3276.
doi: 10.3390/nu14163276.

Hypertensive Disorders of Pregnancy and Fetal Growth Restriction: Clinical Characteristics and Placental Lesions and Possible Preventive Nutritional Targets

Affiliations

Hypertensive Disorders of Pregnancy and Fetal Growth Restriction: Clinical Characteristics and Placental Lesions and Possible Preventive Nutritional Targets

Daniela Denis Di Martino et al. Nutrients. .

Abstract

Background: The purpose of this study was to describe the placental lesions in pregnancies complicated by hypertensive disorders (HDP) and/or fetal growth restriction (FGR) and in uneventful control pregnancies.

Methods: This is a case control study that included singleton pregnancies with HDP and normally grown fetus (HDP-AGA fetus), with HDP and FGR, early FGR, late FGR, and uneventful pregnancies. Feto-placental Doppler velocimetry and sFlt-1/PlGF ratio were performed. Placental histology was evaluated blinded according to the Amsterdam Consensus criteria.

Results: Placental lesions with maternal vascular malperfusion (MVM) were significantly more frequent in HDP-FGR and early FGR (92% and 83%). MVM were significantly associated with abnormal feto-placental Doppler parameters, especially in early FGR. Delayed villous maturation (DVM) was associated with late FGR (83%). HDP-AGA fetus cases presented a heterogeneous pattern of placental lesions, including 60% of cases with MVM, but were not associated with abnormal Doppler feto-placental velocimetry.

Conclusions: We found a prevalence of placental maternal vascular malperfusion in HDP-FGR and early FGR groups. These lesions were also associated with abnormal, anti-, and angiogenic markers. Conversely HDP-AGA fetus and late FGR presented more heterogeneous placental lesions not severe enough to cause feto-placental Doppler anomalies. These conditions are likely associated with different etiologies, such as maternal pre-pregnancy risk factors for metabolic syndrome. These findings suggest a possible preventive nutritional approach in addition to low-dose aspirin in pregnant women with predisposing factors for HDP-AGA fetuses and late FGR.

Keywords: Mediterranean diet; fetal vascular malperfusion; feto-placental Doppler; maternal vascular malperfusion; placenta pathology; preeclampsia; sFlt-1/PlGF ratio.

PubMed Disclaimer

Conflict of interest statement

The authors declare no conflict of interest.

Similar articles

Cited by

References

    1. Bokslag A., van Weissenbruch M., Mol B.W., de Groot C.J. Preeclampsia; short and long-term consequences for mother and neonate. Early Hum. Dev. 2016;102:47–50. doi: 10.1016/j.earlhumdev.2016.09.007. - DOI - PubMed
    1. Myatt L., Redman C.W., Staff A.C., Hansson S., Wilson M., Laivuori H., Poston L., Roberts J.M., Global Pregnancy CoLaboratory Strategy for Standardization of Preeclampsia Research Study Design. Hypertension. 2014;63:1293–1301. doi: 10.1161/HYPERTENSIONAHA.113.02664. - DOI - PubMed
    1. Burton G.J., Redman C.W., Roberts J.M., Moffett A. Pre-eclampsia: Pathophysiology and clinical implications. BMJ. 2019;15:366. doi: 10.1136/bmj.l2381. - DOI - PubMed
    1. Redman C.W., Staff A.C. Preeclampsia, biomarkers, syncytiotrophoblast stress, and placental capacity. Am. J. Obstet. Gynecol. 2015;213:S9.e1–S9.e4. doi: 10.1016/j.ajog.2015.08.003. - DOI - PubMed
    1. Hung T.-H., Skepper J.N., Burton G.J. In Vitro Ischemia-Reperfusion Injury in Term Human Placenta as a Model for Oxidative Stress in Pathological Pregnancies. Am. J. Pathol. 2001;159:1031–1043. doi: 10.1016/S0002-9440(10)61778-6. - DOI - PMC - PubMed